Results 11 to 20 of about 29,614 (185)

Understanding HTLV-I Protease [PDF]

Chemistry & Biology, 2003
AbstractHuman T cell leukemia virus type I (HTLV-I) is a human retrovirus that has been clinically associated with adult T cell leukemia/lymphoma, and it has been designated as a dangerous emerging pathogen by the Centers for Disease Control. Like other retroviruses, proteolytic processing of specific sites in polyprotein precursors by a retroviral ...
Shuker, Suzanne Beckham, Mariani, Victoria L., Herger, Bryan E., Dennison, Kelly J.   +3 more
openaire   +2 more sources

HTLV-I screening in Britain [PDF]

BMJ, 1995
The human T cell leukaemia/lymphoma virus type I (HTLV-I) was isolated nearly 17 years ago from a patient who had what is now called adult T cell leukaemia/lymphoma. This aggressive condition responds poorly to chemotherapy, with a median survival of only a few months.1 HTLV-I is also unequivocally linked with tropical spastic paraparesis, a ...
A, Pagliuca, R, Pawson, G J, Mufti
openaire   +2 more sources

Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil Desempenho de testes sorológicos para o diagnóstico de infecção por HTLV em população de alto-risco de São Paulo, Brasil

Revista do Instituto de Medicina Tropical de São Paulo, 2007
Testing problems in diagnosing human T-lymphotropic virus (HTLV) infection, mostly HTLV-II, have been documented in HIV/AIDS patients. Since December 1998, the Immunology Department of Instituto Adolfo Lutz (IAL) offers HTLV-I/II serology to Public ...
Fabrício Jacob, Elizabeth de los Santos-Fortuna, Raymundo Soares Azevedo, Adele Caterino-de-Araujo   +3 more
doaj   +1 more source

Human T-cell lymphotropic virus types I and II infections in a cohort of patients with neurological disorders in Belém, Pará, Brazil Infecção pelos vírus linfotrópicos humanos de células T tipos I e II entre pacientes com doença neurológica em Belém, Pará, Brasil

Revista do Instituto de Medicina Tropical de São Paulo, 2004
Serum- and/or- cerebrospinal fluid (CSF) samples obtained from 190 patients suffering from chronic, progressive neurological disease were screened for the presence of human T-cell lymphotropic viruses type I (HTLV-I) and type II (HTLV-II) antibodies over
Olinda Macêdo, Telma V. Ribeiro-Lima, Adriana de O. Linhares, Antônio de Moura, Maria de Lourdes C. Gomes, Alexandre C. Linhares   +5 more
doaj   +1 more source

Screening for Human T-Cell Lymphotropic Virus (HTLV) in Pregnant Women in the Peruvian Amazon and Systematic Review with Meta-Analysis of HTLV Infection in Peru

Pathogens, 2021
Background. Human T-cell lymphotropic virus type 1 (HTLV-1) is responsible for tropical spastic paraparesis and HTLV-1-associated leukemia/lymphoma. The infection is endemic in some areas of Peru, but its prevalence in the Peruvian Amazon is not well ...
José-Manuel Ramos-Rincón, Sonia Ortiz-Martínez, María-Esteyner Vásquez-Chasnamote, Eva de-Miguel-Balsa, Olga-Nohelia Gamboa-Paredes, Michael-John Talledo-Albujar, Giovanni López-Campana, Juan Carlos Celis-Salinas, Laura Prieto-Pérez, Miguel Górgolas-Hernández, Martin Casapía-Morales   +10 more
doaj   +1 more source

Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid and Accurate Confirmatory Diagnosis of HTLV-1/2 Infection

Viruses, 2020
Laboratory diagnosis of human T-lymphotropic viruses (HTLV) 1 and 2 infection is performed by serological screening and further confirmation with serological or molecular assays.
Yago Gomes, Adele Caterino-de-Araujo, Karoline Campos, Maria Gisele Gonçalves, Ana Claudia Leite, Marco Antonio Lima, Abelardo Araújo, Marcus Tulius Silva, Otávio Espíndola   +8 more
doaj   +1 more source

A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I

Viruses, 2016
Although the number of human T-cell leukemia virus type-I (HTLV-I)-infected individuals in the world has been estimated at over 10 million, no prophylaxis vaccines against HTLV-I infection are available.
Hideki Fujii, Mamoru Shimizu, Takuya Miyagi, Marie Kunihiro, Reiko Tanaka, Yoshiaki Takahashi, Yuetsu Tanaka   +6 more
doaj   +1 more source

Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules

Retrovirology, 2008
Background Human T-cell leukemia virus type I (HTLV-I) is associated with pulmonary diseases, characterized by bronchoalveolar lymphocytosis, which correlates with HTLV-I proviral DNA in carriers.
Yara Satomi, Miyazato Akiko, Tamayose Maki, Ishikawa Chie, Senba Masachika, Tomita Mariko, Teruya Hiromitsu, Tanaka Yuetsu, Iwakura Yoichiro, Fujita Jiro, Mori Naoki   +10 more
doaj   +1 more source

The Prevalence and Significance of HTLV-I/II Seroindeterminate Western Blot Patterns

Viruses, 2011
Human T-lymphotropic virus type I (HTLV-I) infects an estimated 15–20 million persons worldwide. A number of diseases have been associated with the virus including adult T-cell leukemia (ATL), HTLV-associated myelopathy/tropical spastic paraparesis (HAM ...
Yoshimi Akahata, Anna Abrams, Steven Jacobson   +2 more
doaj   +1 more source

Risk Factors for Human T Cell Lymphotropic Virus Type I among Injecting Drug Users in Northeast Brazil: Possibly Greater Efficiency of Male to Female Transmission

Memorias do Instituto Oswaldo Cruz, 1999
It was observed in the city of Salvador, State of Bahia, the highest seroprevalence of human T cell lymphotropic virus type 1 (HTLV-I) infection in Brazil as demonstrated by national wide blood bank surveys.
Inês Dourado, Tarcísio Andrade, Catherine L Carpenter, Bernardo Galvão-Castro   +3 more
doaj   +1 more source